文献速递乳腺泌尿生殖MRPETCT

基于MRI与FDG-PET/CT评估早期乳腺癌腋窝淋巴结转移的Meta分析

MRI and FDG-PET/CT based assessment of axillary lymph node metastasis in early breast cancer: a meta-analysis.
PubMed 文献 · Clin Radiol · 2017-01-27

该Meta分析纳入21项研究,评估MRI与FDG-PET/CT对乳腺癌腋窝淋巴结分期的诊断效能。MRI与PET/CT合并特异度均为0.93,但MRI合并敏感度0.82显著高于PET/CT的0.64,MRI诊断比值比51.28也显著高于PET/CT的18.84。USPIO增强MRI对早期乳腺癌腋窝淋巴结转移显示高诊断准确性。

要点

  • MRI合并敏感度0.82显著高于PET/CT的0.64,两者合并特异度均为0.93。
  • MRI诊断比值比51.28显著高于PET/CT的18.84。
  • USPIO增强MRI对早期乳腺癌腋窝淋巴结转移显示高诊断准确性。

核心结论

  • Meta分析提示,MRI诊断淋巴结转移的敏感度高于PET/CT,且作为无创影像诊断技术具有较高潜力;USPIO增强MRI对早期乳腺癌腋窝淋巴结转移显示高诊断准确性。

研究设计与样本

  • 系统检索MEDLINE和EMBASE数据库2008年1月至2015年10月发表的诊断研究,共纳入21项评估MRI或PET/CT诊断乳腺癌腋窝淋巴结状态的合格研究,采用QUADAS标准评价研究质量,MRI和PET/CT分别采用随机效应模型和固定效应模型分析敏感度与特异度。

诊断标准与关键数值

  • MRI合并敏感度0.82(95%CI:0.78-0.85),合并特异度0.93(95%CI:0.92-0.94),诊断比值比51.28(95%CI:22.44-117.17);PET/CT合并敏感度0.64(95%CI:0.59-0.69),合并特异度0.93(95%CI:0.90-0.95),诊断比值比18.84(95%CI:11.71-31.76)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To evaluate the accuracy of magnetic resonance imaging (MRI) and combined 2-[18F]-fluoro-2-deoxy-d-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) for N staging of breast cancer.

MATERIALS AND METHODS: A search for relevant diagnostic studies published between January 2008 and October 2015 was conducted in the MEDLINE and EMBASE databases. The quality of the studies was assessed using Quality Assessment of Diagnostic Accuracy Studies (QUADAS) criteria. Sensitivity and specificity were analysed using the random-effect model and fixed effect model for MRI and PET/CT, respectively.

RESULTS: A total of 21 eligible studies were evaluated for the efficacy of MRI or PET/CT for diagnosing axillary lymph node status in breast cancer patients. The pooled specificities of MRI and PET/CT were similar at 0.93 (95% confidence interval [CI]: 0.92-0.94) and 0.93 (95% CI: 0.90-0.95), respectively; however, the pooled sensitivity of MRI was (0.82; 95% CI: 0.78-0.85) significantly greater than PET/CT (0.64; 95% CI: 0.59-0.69)]. Further analysis revealed that MRI had a significantly higher diagnostic odds ratio (DOR) value of 51.28 (95% CI: 22.44-117.17) compared to PET/CT at 18.84 (95% CI: 11.71-31.76).

CONCLUSION: The present meta-analysis suggests that MRI not only has the higher sensitivity for lymph node metastasis diagnosis compared to PET/CT, but also has high potential for being used as a non-invasive imaging diagnostic technique. Furthermore, the ultra-small super paramagnetic iron oxide (USPIO)-enhanced MRI showed high diagnostic accuracy for identifying axillary lymph node metastases in early-stage breast cancer patients.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Liang X, Yu J, Wen B, et al. MRI and FDG-PET/CT based assessment of axillary lymph node metastasis in early breast cancer: a meta-analysis. Clin Radiol. 2017. PMID: 28139203. doi:10.1016/j.crad.2016.12.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。